Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded.

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded.
复制标题

DOI:
10.1038/nrmicro1927
复制
发表时间:
2008-07
期刊:
Nature reviews. Microbiology
影响因子:
--
通讯作者:
--
中科院分区:
其他
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

基于我们对病毒生物学和遗传学的更好的理解,以及我们对许多不同类型癌症的更好的了解,病毒疗法目前正在经历复兴。病毒可以通过结合三种类型的修饰重新编程为溶瘤载体:靶向、武装和屏蔽。靶向引入了多层癌症特异性,提高了安全性和有效性;武装通过表达前药物转换酶和细胞因子而发生;聚合物涂层和不同包膜或衣壳的顺序使用提供了对宿主免疫反应的屏蔽。与化疗和放射治疗相结合,基于病毒的疗法开始在癌症临床实践中占据一席之地。
Virotherapy is currently undergoing a renaissance, based on our improved understanding of virus biology and genetics and our better knowledge of many different types of cancer. Viruses can be reprogrammed into oncolytic vectors by combining three types of modification: targeting, arming and shielding. Targeting introduces multiple layers of cancer specificity and improves safety and efficacy; arming occurs through the expression of prodrug convertases and cytokines; and coating with polymers and the sequential usage of different envelopes or capsids provides shielding from the host immune response. Virus-based therapeutics are beginning to find their place in cancer clinical practice, in combination with chemotherapy and radiation.
DOI: 10.1128/jvi.77.21.11367-11377.2003
发表时间: 2003-11-01
影响因子: 5.4
作者:
Belousova, N;Korokhov, N;Krasnykh, V
通讯作者: Krasnykh, V
DOI: 10.1126/science.277.5332.1630
发表时间: 1997-09-12
期刊: SCIENCE
影响因子: 56.9
作者:
Darnell, JE
通讯作者: Darnell, JE
DOI: 10.1038/nbt0598-444
发表时间: 1998-05-01
影响因子: 46.9
作者:
Chase, M;Chung, RY;Chiocca, EA
通讯作者: Chiocca, EA
DOI: 10.1128/jvi.75.10.4792-4801.2001
发表时间: 2001-05-01
影响因子: 5.4
作者:
Croyle, MA;Chirmule, N;Wilson, JM
通讯作者: Wilson, JM
DOI: 10.1016/j.virol.2006.09.023
发表时间: 2007-03-01
期刊: VIROLOGY
影响因子: 3.7
作者:
Childs, Kay;Stock, Nicola;Goodbourn, Stephen
通讯作者: Goodbourn, Stephen